Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Takahisa Eriguchi"'
Autor:
Hiromichi Ishiyama, Hideyasu Tsumura, Hisato Nagano, Motoi Watanabe, Eiichi Mizuno, Masashi Taka, Hiroaki Kobayashi, Takahisa Eriguchi, Hajime Imada, Koji Inaba, Katsumasa Nakamura
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract To report outcomes and risk factors of ultrahypofractionated (UHF) radiotherapy for Japanese prostate cancer patients. This multi-institutional retrospective analysis comprised 259 patients with localized prostate cancer from 6 hospitals. A
Externí odkaz:
https://doaj.org/article/677e0ef19ae74f80ac3d0cd39cbf41cc
Autor:
Feiqian Wang, Kazushi Numata, Atsuya Takeda, Katsuaki Ogushi, Hiroyuki Fukuda, Koji Hara, Makoto Chuma, Takahisa Eriguchi, Yuichirou Tsurugai, Shin Maeda
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0245076 (2021)
AimTo evaluate the safety and efficacy of the administration of radiofrequency ablation (RFA) and stereotactic body radiotherapy (SBRT) in the short term to the same patients in Barcelona Clinical Liver Cancer (BCLC) stages 0-B1.MethodsFrom April 201
Externí odkaz:
https://doaj.org/article/a6595a46259d484a8378d47f6811e8d8
Autor:
Masahiro Okada, Kazushi Numata, Hiromi Nihonmatsu, Kengo Tomita, Atsuya Takeda, Kenichiro Tago, Tomoko Hyodo, Takahisa Eriguchi, Masayuki Nakano
Publikováno v:
Diagnostics, Vol 12, Iss 5, p 1072 (2022)
We studied five pathological specimens from five patients at 1.5, 3.0, 4.0, 13.5, and 14.0 months after radiotherapy for HCC. Four needle biopsies were obtained to investigate liver parenchyma of focal liver reaction (FLR) around treated HCC, when pa
Externí odkaz:
https://doaj.org/article/3111defcc373449fb4f6f6ea39695a99
Autor:
Shuichi Nishimura, Toshio Ohashi, Tetsuo Momma, Masanori Sakayori, Takahisa Eriguchi, Tomoki Tanaka, Shoji Yamashita, Takeo Kosaka, Mototsugu Oya, Naoyuki Shigematsu
Publikováno v:
Cancer Medicine, Vol 7, Iss 5, Pp 1794-1801 (2018)
Abstract Prostate‐specific antigen nadir (nPSA) after radiotherapy for localized prostate cancer has been investigated as a predictor. However, nPSA usually requires several years, limiting its clinical utility. We investigated the significance of
Externí odkaz:
https://doaj.org/article/5bca0dba7c164edc967821e0f22a3ccb
Autor:
Daisuke Kanda, Takashi Hanada, Kayo Yoshida, Tomoki Tanaka, Takahisa Eriguchi, Atsunori Yorozu, Toshio Ohashi, Naoyuki Shigematsu
Publikováno v:
Journal of Radiation Research. 64:590-598
We investigated dose perturbations caused by 125I seeds in patients undergoing supplemental external beam radiotherapy (EBRT) for prostate cancer. We examined two types of nonradioactive seed models: model 6711 and model STM1251. All experiments were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb6cedbb43f3631584adc0efd8cd512c
https://doi.org/10.1093/jrr/rrad023
https://doi.org/10.1093/jrr/rrad023
Autor:
Yuto Kimura, Atsuya Takeda, Takahisa Eriguchi, Yohei Oku, Yuichi Kibe, Yuichiro Tsurugai, Naoki Nakamura
Publikováno v:
Acta Oncologica. 61:104-110
Background The feasibility of marker-less stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC) has not yet been established, and, thus, was examined in the present study. Material and methods We retrospectively investigated patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26c67937ab08efa05cd1b07467d45938
https://doi.org/10.1080/0284186x.2021.2001566
https://doi.org/10.1080/0284186x.2021.2001566
Autor:
Nobuyuki Horita, Takahisa Eriguchi, Takeshi Kaneko, Naoko Sanuki, Yudai Tateishi, Atsuya Takeda, Yuichi Kibe, Yuichiro Tsurugai
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:143-151
Purpose We investigated whether delivery of a high biologically effective dose (BED) to primary tumors affects systemic outcomes of cancer-specific death (CSD) and overall survival (OS) rates after stereotactic body radiation therapy (SBRT) in patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02f2126233caa2a8fea53c4517f5bd31
https://doi.org/10.1016/j.ijrobp.2021.04.014
https://doi.org/10.1016/j.ijrobp.2021.04.014
Autor:
Naoko Sanuki, Atsuya Takeda, Takahisa Eriguchi, Yuichiro Tsurugai, Yudai Tateishi, Yuichi Kibe, Takeshi Akiba, Tsuyoshi Fukuzawa, Nobuyuki Horita
Publikováno v:
Radiotherapy and Oncology. 183:109664
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d22c5ba56c1fc1a5d7724aa5aad6e59e
https://doi.org/10.1016/j.radonc.2023.109664
https://doi.org/10.1016/j.radonc.2023.109664
Autor:
Takafumi Nemoto, Atsuya Takeda, Yukinori Matsuo, Noriko Kishi, Takahisa Eriguchi, Etsuo Kunieda, Ryusei Kimura, Naoko Sanuki, Yuichiro Tsurugai, Masamichi Yagi, Yousuke Aoki, Yohei Oku, Yuto Kimura, Changhee Han, Naoyuki Shigematsu
Publikováno v:
JCO clinical cancer informatics. 6
PURPOSE Clear evidence indicating whether surgery or stereotactic body radiation therapy (SBRT) is best for non–small-cell lung cancer (NSCLC) is lacking. SBRT has many advantages. We used artificial neural networks (NNs) to predict treatment outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd37a0dd14b322f226de2e5dd1c9f8bd
https://pubmed.ncbi.nlm.nih.gov/35749675
https://pubmed.ncbi.nlm.nih.gov/35749675
Autor:
Takahisa Eriguchi, Atsuya Takeda, Takafumi Nemoto, Yuichiro Tsurugai, Naoko Sanuki, Yudai Tateishi, Yuichi Kibe, Takeshi Akiba, Mari Inoue, Kengo Nagashima, Nobuyuki Horita
Publikováno v:
Cancers. 14(15)
Variations in dose prescription methods in stereotactic body radiotherapy (SBRT) for early stage non-small-cell lung cancer (ES-NSCLC) make it difficult to properly compare the outcomes of published studies. We conducted a comprehensive search of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8828b8b296a4f90ea2e79eadd856346
https://pubmed.ncbi.nlm.nih.gov/35954478
https://pubmed.ncbi.nlm.nih.gov/35954478